Optobionics

Optobionics Overview

Founded 1997
Founded
Status Acquired/​Merged
Employees 15
Employees
Latest Deal Type M&A
Financing Rounds 6

Optobionics General Information

Description

Developer of an artificial retina device created for stimulating and modulating eye sight diseases. The company's device includes microchips that are implanted to neurotrophic rescue effect resulting in a degree of vision recovery that has included visual acuity, contrast and colour perception, and expansion of the visual field, enabling patients to receive treatment of vision loss From retinitis pigmentosa.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Surgical Devices
Other Industries
Therapeutic Devices
Primary Office
  • 386 Pennsylvania Avenue
  • Suite 3N
  • Glen Ellyn, IL 60137
  • United States
+1 (630) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Optobionics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Optobionics‘s full profile, request access.

Request a free trial

Optobionics Executive Team (6)

Name Title Board Seat Contact Info
Mike Selzer President & Chief Executive Officer
Vincent Chow Ph.D Co-Founder
Peter Lord Vice President of Development
Vincent Colombeau Vice President of Engineering
David Pincus Vice President of Finance

1 Former Executive

Optobionics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Optobionics‘s full profile, request access.

Request a free trial